Pomegranate’s power: Studies show promise in cardiovascular and diabetic health

Sen­ate Fi­nance Chair Ron Wyden (D-OR) is press­ing Pfiz­er over its tax prac­tices as part of his in­ves­ti­ga­tion in­to how large phar­ma com­pa­nies use sub­sidiaries

San­doz said Tues­day that the FDA signed off on two of its biosim­i­lars to Am­gen’s bone drug deno­sum­ab. But as with oth­er high-pro­file biosim­i­lar ap­provals,

Af­ter spend­ing near­ly 20 years to­geth­er in lead­er­ship roles at In­cyte, help­ing bring to mar­ket five med­i­cines, Wen­qing Yao and Reid Hu­ber are re­unit­ing on